Skip to content

15th HIV Resistance Workshop: can new Tibotec NNRTI overcome cross-class resistance?

FDA approves first three-drug fixed-dose tablet for PEPFAR use

2005 decline in UK's sexual health 'disappointing'

Zimbabwe observes a reduction in HIV prevalence, but why?

California court says people with HIV can be sued for passing virus, even if untested

Modelling study predicts efficacy and cost-effectiveness of HIV treatment after single-dose nevirapine

AmfAR funds 'bold' viral eradication studies

Kaletra receives EU marketing approval; developing countries registration 'moving forward'

Warning issued over bleeding within the skull in patients taking tipranavir